CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-05-03 | MAYLEBEN TIMOTHY M President and CEO | Grant or award · Stock Option (right to buy) | +520,000 | $2.49 | $1.3M | 520,000 |
| 2012-01-04 | Durbin Scott CFO | Sale | −40,000 | $1.80 | $72K | 0 |
| 2011-08-11 | Durbin Scott CFO | Purchase | +10,000 | $2.24 | $22K | 40,850 |
| 2011-08-11 | CRESSWELL RONALD M Director | Purchase | +20,000 | $2.22 | $44K | 40,000 |
| 2011-08-10 | Durbin Scott CFO | Purchase | +850 | $2.18 | $2K | 30,850 |
| 2011-08-08 | MAYLEBEN TIMOTHY M President and CEO | Purchase | +10,000 | $2.11 | $21K | 133,000 |
| 2011-08-05 | MAYLEBEN TIMOTHY M President and CEO | Purchase | +20,000 | $2.36 | $47K | 123,000 |
| 2011-03-24 | CRESSWELL RONALD M Director | Purchase | +20,000 | $2.19 | $44K | 20,000 |
| 2011-03-21 | Rubino Alan L Director | Grant or award · Stock Option (right to buy) | +100,000 | $2.26 | $226K | 100,000 |
| 2011-03-21 | Urschel Harold C Jr Director | Grant or award · Stock Option (right to buy) | +105,725 | $2.26 | $239K | 105,725 |
| 2011-03-21 | SIMS NELSON M Director | Grant or award · Stock Option (right to buy) | +100,000 | $2.26 | $226K | 100,000 |
| 2011-03-21 | ZERBE ROBERT L MD Director | Grant or award · Stock Option (right to buy) | +100,000 | $2.26 | $226K | 100,000 |
| 2011-03-21 | CRESSWELL RONALD M Director | Grant or award · Stock Option (right to buy) | +100,250 | $2.26 | $227K | 100,250 |
| 2011-03-21 | MAYLEBEN TIMOTHY M CEO, President and Director | Grant or award · Stock Option (right to buy) | +699,875 | $2.26 | $1.6M | 699,875 |
| 2011-03-21 | Durbin Scott CFO and Treasurer | Grant or award · Stock Option (right to buy) | +170,000 | $2.26 | $384K | 170,000 |
| 2011-03-21 | Bartel Ronnda Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +156,500 | $2.26 | $354K | 156,500 |
| 2011-03-21 | Watling Sharon Vice President | Grant or award · Stock Option (right to buy) | +221,000 | $2.26 | $499K | 221,000 |
| 2011-03-04 | Durbin Scott Chief Financial Officer | Purchase | +13,537 | $2.17 | $29K | 30,000 |
| 2011-03-03 | MAYLEBEN TIMOTHY M CEO and President | Purchase | +14,832 | $2.14 | $32K | 103,000 |
| 2011-03-02 | MAYLEBEN TIMOTHY M CEO and President | Purchase | +6,550 | $2.09 | $14K | 88,168 |
Page 70 of 75 · 1,497 trades